| __timestamp | Corcept Therapeutics Incorporated | Sarepta Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 34916000 | 49315000 |
| Thursday, January 1, 2015 | 36949000 | 75043000 |
| Friday, January 1, 2016 | 45240000 | 83749000 |
| Sunday, January 1, 2017 | 62416000 | 122682000 |
| Monday, January 1, 2018 | 81289000 | 207761000 |
| Tuesday, January 1, 2019 | 100359000 | 284812000 |
| Wednesday, January 1, 2020 | 105326000 | 317875000 |
| Friday, January 1, 2021 | 122356000 | 282660000 |
| Saturday, January 1, 2022 | 152848000 | 451421000 |
| Sunday, January 1, 2023 | 184259000 | 481871000 |
In pursuit of knowledge
In the competitive world of biotechnology, managing operational costs is crucial for success. This analysis compares the Selling, General, and Administrative (SG&A) expenses of Sarepta Therapeutics, Inc. and Corcept Therapeutics Incorporated from 2014 to 2023. Over this period, Sarepta's SG&A expenses surged by approximately 878%, reflecting its aggressive growth strategy and expansion efforts. In contrast, Corcept's expenses increased by about 428%, indicating a more measured approach.
By 2023, Sarepta's SG&A expenses were more than double those of Corcept, highlighting its significant investment in administrative and sales functions. This trend underscores the differing strategic priorities of these companies, with Sarepta focusing on rapid expansion and Corcept maintaining a steady growth trajectory. Understanding these financial dynamics offers valuable insights into the operational strategies of leading biotech firms.
Johnson & Johnson or Sarepta Therapeutics, Inc.: Who Manages SG&A Costs Better?
SG&A Efficiency Analysis: Comparing Merck & Co., Inc. and Sarepta Therapeutics, Inc.
Bristol-Myers Squibb Company and Corcept Therapeutics Incorporated: SG&A Spending Patterns Compared
Comparing SG&A Expenses: Vertex Pharmaceuticals Incorporated vs Corcept Therapeutics Incorporated Trends and Insights
Selling, General, and Administrative Costs: Sarepta Therapeutics, Inc. vs Ascendis Pharma A/S
Sarepta Therapeutics, Inc. or Opthea Limited: Who Manages SG&A Costs Better?
Comparing SG&A Expenses: Sarepta Therapeutics, Inc. vs Axsome Therapeutics, Inc. Trends and Insights
Breaking Down SG&A Expenses: Sarepta Therapeutics, Inc. vs Lantheus Holdings, Inc.
Comparing SG&A Expenses: Blueprint Medicines Corporation vs Corcept Therapeutics Incorporated Trends and Insights
Who Optimizes SG&A Costs Better? Corcept Therapeutics Incorporated or TG Therapeutics, Inc.
Corcept Therapeutics Incorporated and Wave Life Sciences Ltd.: SG&A Spending Patterns Compared
Selling, General, and Administrative Costs: Corcept Therapeutics Incorporated vs Taro Pharmaceutical Industries Ltd.